Identification and functional characterization of novel variants of MAPT and GRN in Chinese patients with frontotemporal dementia

Hong-Rong Cheng,Rong-Rong Lin,Hong-Lei Li,Yan-Yan Xue,Pei-Rong Gao,Dian-Fu Chen,Qing-Qing Tao,Zhi-Ying Wu
DOI: https://doi.org/10.1016/j.neurobiolaging.2022.12.009
IF: 5.133
2022-12-25
Neurobiology of Aging
Abstract:Frontotemporal dementia (FTD) is the second most common cause of dementia after Alzheimer's disease, characterized by distinct changes in behavior, personality, and language. Our study performed whole exome sequencing (WES) and repeat-primed PCR analysis in 29 unrelated FTD patients. Consequently, two known pathogenic variants ( MAPT : p.P301L; TBK1 : p.E448fs), and four novel variants ( MAPT : p.R406Q, p.D430H, p.A330D; GRN : c.350-2A>G) were identified. The functional analysis results showed that phosphorylated tau levels were higher in cells expressing p.R406Q and p.D430H tau than those expressing wild-type (WT) tau, especially at the Thr205, Thr231, and Ser396 phosphorylation epitopes. Besides, the p.R406Q and p.D430H variants of MAPT impaired the ability of tau to bind to the microtubules and increased tau self-aggregation. Furthermore, we found that the c.350-2A>G variant caused exon 5 skipping. Our results showed that p.R406Q, p.D430H, and c.350-2A>G variants were classified as pathogenic. Finally, we summarized the clinical characterization of patients carrying pathogenic variants of MAPT in the East Asia populations. Our results broaden the genetic spectrum of FTD with MAPT and GRN variants.
neurosciences,geriatrics & gerontology,gerontology
What problem does this paper attempt to address?